AMAG Pharmaceuticals, Inc. (NasdaqGS:AMAG) announces a share repurchase program. Under the program, the company will repurchase up to $60 million worth of its common stock. The company may purchase its shares from time to time in the open market or in privately negotiated transactions.

The company may also from time to time establish a trading plan under Rule 10b5-1 of the Securities and Exchange Act of 1934 to facilitate purchases of its shares under this program. The share repurchase program underscores the company's confidence in its corporate strategy to drive long-term sustainable growth and build shareholder value. The number of shares repurchased and the timing of the purchases will depend on a number of factors, including share price, trading volume and general market conditions, along with working capital requirements, general business conditions and other factors.

The share repurchase program has no time limit and may be suspended for periods or discontinued at any time. As of December 31, 2015, the company had 34,700,000 shares of its common stock outstanding.